BioSpace News Archive

Artivion, Inc., a leading cardiac and vascular surgery company focused on aortic disease, announced that first quarter 2023 financial results will be released on Thursday, May 4, 2023 after the market closes.

Paragon 28, Inc., a leading medical device company exclusively focused on the foot and ankle orthopedic market, announced it will report financial results for the first quarter 2023 after market close on Thursday, May 4, 2023.

Moderna, Inc. (Nasdaq:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Thursday, May 4, 2023 to report its first quarter 2023 financial results, and provide a corporate update.

The Insight Partners published latest research report on “Respiratory Inhalers Market Size Report, Share, Trends, Growth and Revenue Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type, and Disease Indication” the global market size is expected to grow from USD 31,144.56 million in 2022 to USD 43,446.19 million by 2028; it is estimated to record a CAGR of 5.7% from 2022 to 2028.

In accordance with article 14 of the Act of 2 May 2007 on the disclosure of large shareholdings, Nyxoah SA announces that it received two transparency notifications as detailed below.

AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH) announced today that it will report its first quarter 2023 financial results after the close of the U.S. financial markets on Thursday, May 11, 2023.

LeMaitre Vascular, Inc., a provider of vascular devices, implants and services, announced it has entered into an agreement with Aziyo Biologics, Inc. to become the exclusive distributor of Aziyo’s cardiovascular patches in the United States.

Biora Therapeutics, Inc. (Nasdaq: BIOR) today announced that it will participate in IBD Innovate: Product Development for Crohn’s & Colitis, an event hosted by the Crohn’s & Colitis Foundation to showcase innovative product development programs in inflammatory bowel disease (IBD), which will take place in New York City on April 26, 2023.

AptarGroup, Inc., a global leader in drug delivery, consumer product dispensing and active material science solutions and services, declared a quarterly cash dividend of $0.38 per share.

Khiron Life Sciences Corp. (TSXV: KHRN) (OTCQX: KHRNF) (FSE: A2JMZC) (“Khiron” or the “Company”), today announces the completion of its first phase of business optimization in Colombia, to focus on its unique high-margin B2C business model, centered around its clinic operations.